{"id":"W3101241490","doi":"10.1016/j.ophtha.2020.11.017","title":"Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration","year":2020,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute for Health and Care Research","keywords":"Medicine; Macular degeneration; Ranibizumab; Ophthalmology; Choroidal neovascularization; Visual acuity; Adverse effect; Pro re nata; Clinical trial; Randomized controlled trial; Diabetic retinopathy; Surgery; Internal medicine; Bevacizumab; Diabetes mellitus; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008285676,0.002207765,0.003983325,0.0006592083,0.0006542619,0.001389234,0.0008698592,0.001882261,0.004588897],"category_scores_gemma":[0.01020001,0.0008383348,0.003852498,0.0006514358,0.0008922954,0.001389181,0.0004930765,0.002674982,0.0006434068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007583455,"about_ca_system_score_gemma":0.00156038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007431761,"about_ca_topic_score_gemma":0.002317232,"domain_scores_codex":[0.9954011,0.003086674,0.0003663697,0.0003865777,0.0004409878,0.0003182562],"domain_scores_gemma":[0.9942042,0.002228781,0.001842059,0.0004614254,0.0005888001,0.0006747518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9655076,0.006555005,0.001398966,0.001086362,0.004810288,0.00005558769,0.0000584441,0.0002788464,0.001654263,0.00008326027,0.001139423,0.01737194],"study_design_scores_gemma":[0.944198,0.04815269,0.00403388,0.00004462725,0.002117592,0.00004180764,0.00001654102,0.0002626591,0.0003710552,0.00009813226,0.0006457001,0.00001736568],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9540017,0.0229913,0.002584193,0.001161266,0.001066878,0.01173398,0.003095697,0.0002727312,0.003092162],"genre_scores_gemma":[0.9705322,0.007049968,0.00399824,0.00187501,0.001119166,0.01043634,0.002185842,0.00006680243,0.002736402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008285676,"threshold_uncertainty_score":0.04381937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02742489547904702,"score_gpt":0.3335763627349561,"score_spread":0.3061514672559091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}